Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s diseaseEvandro Fei Fang, Vilhelm A. Bohr, Mansour Akbari et al.|Nature Neuroscience|2019Cited by 1.7k
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humansMaria L. Maccecchini, Nigel H. Greig, Mee Young Chang et al.|Journal of Neurology Neurosurgery & Psychiatry|2012Cited by 90
Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the ratShigeru Genka, Nigel H. Greig, Joseph Deutsch et al.|Cancer Chemotherapy and Pharmacology|1990Cited by 50
Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucilShigeru Genka, Nigel H. Greig, Joseph Deutsch et al.|Clinical & Experimental Metastasis|1993Cited by 34
Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of NeurodegenerationKatherine O. Kopp, Nigel H. Greig|Biomolecules|2024Cited by 15